John S Condeelis

16PUBLICATIONS
41CO-AUTHORS
MechanobiologyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tō te Māori mātauranga hangarau, mātauranga atu anō, mātauranga haere tonu, me te mātauranga hapori (Māori technical, further, continuing and community education)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 27, 2025
Paclitaxel causes de novo induction of invasive breast cancer cells by repolarizing tumor-associated macrophages.

Madeline Friedman-DeLuca, George S Karagiannis, Camille L Duran

|Nov 12, 2024
Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast Cancer.

Jesus D Anampa, Daniel L Flynn, Cynthia Leary

|Sep 14, 2022
Mechanisms and roles of podosomes and invadopodia.

Stefan Linder, Pasquale Cervero, Robert Eddy

|Sep 02, 2022
Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapy.

George S Karagiannis, Anthony Bianchi, Luis Rivera Sanchez

|Feb 03, 2022
Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells.

Lucia Borriello, Anouchka Coste, Brian Traub

|Dec 16, 2021
Live tumor imaging shows macrophage induction and TMEM-mediated enrichment of cancer stem cells during metastatic dissemination.

Ved P Sharma, Binwu Tang, Yarong Wang

Pageof 3

Frequent Collaborators

8 joint publications

David Entenberg

3 joint publications

Camille L Duran

3 joint publications

Jesus M Anampa

3 joint publications

Joseph A Sparano